Side-by-side comparison

CJC-1295

Secretagogue PeptideSafety 7/10

Growth hormone secretagogue research

vs

Tesamorelin

Secretagogue PeptideSafety 8/10

Visceral fat / lipolysis research

CJC-1295
Tesamorelin
Cheapest price
$12.78 /5mg
$44.99 /10mg
Vendors stocking
21
28
Safety rating
7/10
8/10
Administration
Subcutaneous injection
Subcutaneous injection

Price Comparison — 2026

CJC-1295

VendorPrice
Alpha Peptides$12.78 /5mgBuy →
Puratek Peptides$20.23 /5mgBuy →
Hydro Research$24.00 /5mgBuy →
Ascension Peptides$25.00 /5mgBuy →
Licensed Peptides$29.00 /5mgBuy →5% off via our link·auto

Tesamorelin

VendorPrice
Alpha Peptides$44.99 /10mgBuy →
Puratek Peptides$47.23 /10mgBuy →
Amino Club$51.79 /10mgBuy →
Peptyx Labs$52.00 /10mgBuy →
SomaChems$59.99 /10mgBuy →
Optimum Formula$62.99 /10mgBuy →

Vendors Carrying Both

18 vendors stock both CJC-1295 and Tesamorelin — convenient if you want to bundle an order.

Alpha PeptidesCJC-1295: $12.78Tesamorelin: $44.99Visit →
Puratek PeptidesCJC-1295: $20.23Tesamorelin: $47.23Visit →
SomaChemsCJC-1295: $59.98Tesamorelin: $59.99Visit →
Midwest PeptideCJC-1295: $31.50Tesamorelin: $67.49Visit →
Ascension PeptidesCJC-1295: $25.00Tesamorelin: $70.00Visit →
Novatherix LaboratoriesCJC-1295: $36.00Tesamorelin: $71.99Visit →
HolasCJC-1295: $31.50Tesamorelin: $75.60Visit →
Pinnacle Peptide LabsCJC-1295: $34.00Tesamorelin: $76.49Visit →
Core PeptidesCJC-1295: $41.00Tesamorelin: $79.00Visit →
PeptiraCJC-1295: $39.50Tesamorelin: $89.00Visit →
Modern AminosCJC-1295: $60.00Tesamorelin: $92.00Visit →
Onyx ResearchCJC-1295: $45.00Tesamorelin: $95.00Visit →
Ignite PeptidesCJC-1295: $25.00Tesamorelin: $100.00Visit →
Evolve PeptidesCJC-1295: $31.41Tesamorelin: $110.50Visit →
Licensed PeptidesCJC-1295: $29.00Tesamorelin: $130.99Visit →
Pantheon PeptidesCJC-1295: $53.14Tesamorelin: $142.56Visit →
LeoLab RxCJC-1295: $75.00Tesamorelin: $220.00Visit →
PeptuviaCJC-1295: $95.00Tesamorelin: $238.00Visit →

Safety Notes

CJC-1295

FDA: Not FDA-approved

Studied in human PK trials; well-tolerated; water retention, tingling reported; short-acting

Tesamorelin

FDA: FDA-approved (Egrifta)

Approved for HIV lipodystrophy; injection site reactions; fluid retention; well-characterized

Failed to fetch